Prophylactic aortic root replacement on Marfan patients undergoing mitral valve repair

A. Kalangos, S.M. Cherian, J. Jolou, J.-C. Pache, H. Muller, P.O. Myers, M. Cikirikcioglu

References

1. Aalberts JJ, Waterbolk TW, van Tintelen JP, et al. Prophylactic aortic root surgery in patients with Marfan syndrome: 10 years' experience with a protocol based on body surface area. Eur J Cardiothorac Surg. 2008;34:589-594.
2. Alexiou C, Langley S.M, Charlesworth P, et al. Aortic root replacement in patients with Marfan's syndrome: the Southampton experience. Ann. Thorac. Surg. 2001;72:1502-1507.
3. Cañadas V, Vilacosta I, Bruna I, Fuster V. Nat Rev. Cardiol. 2010;7:256-265 (266-276).
4. Carpentier A. Cardiac valve surgery – the «French correction». J. Thorac. Cardiovasc. Surg. 1983;86:323-337.
5. David TE, Armstrong S, Maganti M, et al. Long-term results of aortic valve-sparing operations in patients with Marfan syndrome. J Thorac Cardiovasc Surg. 2009;138:859-864.
6. Davies RR, Gallo A, Coady MA, et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 2006;81:169-177.
7. De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;24:417-426.
8. Fleischer KJ, Nousari HC, Anhalt GJ, et al. Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan’s syndrome. Ann Thorac Surg. 1997;63:1012-1017.
9. Fornes P, Heudes D, Fuzellier JF, et al. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol 1999;8:81-92.
10. Gillinov AM, Hulyalkar A, Cameron DE, et al. Mitral valve operation in patients with the Marfan syndrome. J Thorac Cardiovasc Surg. 1994;107:724-731.
11. Gott VL, Cameron DE, Alejo DE, et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann Thorac Surg. 2002;73:438-443.
12. Gott VL, Greene PS, Alejo DE, et al. Replacement of the aortic root in patients with Marfan's syndrome. New Engl J Med. 1999;29:1307-1313.
13. Hirata K, Triposkiadis F, Sparks E, et al. The Marfan syndrome: cardiovascular physical findings and diagnostic correlates. Am Heart J. 1992;123:743-752.
14. Kalangos A, Sierra J, Vala D, et al. Annuloplasty for valve repair with a new biodegradable ring: an experimental study. J Heart Valve Dis. 2006;15:783-790.
15. Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation. 2008;27:2802-2813.
16. Konstantinov IE, Jalali H. Total chordal augmentation in a child with Marfan syndrome and severe mitral insufficiency. Tex Heart Inst. J. 2007;34:423-424.
17. Legget ME, Unger TA, O'Sullivan CK, et al. Aortic root complications in Marfan's syndrome: identification of a lower risk group. Heart. 1996;75:389-395.
18. Meijboom LJ, Timmermans J, Zwinderman AH, et al. Aortic root growth in men and women with the Marfan's syndrome. Am. J. Cardiol. 2005;15:1441-1444.
19. Miller DC. Valve-sparing aortic root replacement in patients with the Marfan syndrome. J Thorac Cardiovasc Surg. 2003;125. P. 773-778.
20. Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg.1996;62:932-935.
21. Morganroth J, Jones RH, Chen CC, et al. Two-dimensional echocardiography in mitral, aortic and tricuspid valve prolapsed. Am J Cardiol. 1986;46:1164.
22. Murdoch JL, Walker BA, Halpern BL, et al. Life expectancy and causes of death in the Marfan syndrome. New Engl. J. Med. 1972;13:804-808.
23. Pereira L, Andrikopoulos K, Tian J, et al. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat. Genet. 1997;17:218-222.
24. Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. New Engl J Med. 1979;5. P. 772-777.
25. Pyeritz RE, Wappel MA. Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history. Am J Med. 1983;74:797-807.
26. Roman MJ, Devereux RB, Kramer-Fox R, Spitzer M.C. Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome. Am J Cardiol. 1989;1:317-321.
27. Silverman NH, Gerlis LM, Horowitz ES, et al. Pathologic elucidation of the echocardiographic features of Ebstein's malformation of the morphologically tricuspid valve in discordant atrioventricular connections. Am J Cardiol. 1995;15. P. 1277-1283.
28. Smith JA, Fann JI, Miller DC, et al. Surgical management of aortic dissection in patients with the Marfan syndrome. Circulation. 1994;90:II235-242.
29. Svensson LG, Blackstone EH, Feng J, et al. Are Marfan syndrome and marfanoid patients distinguishable on long-term follow-up? Ann Thorac Surg. 2007;83:1067-1074.
30. Svensson LG, Crawford ES, Coselli JS, et al. Impact of cardiovascular operation on survival in the Marfan patient. Circulation. 1989;80:I233-242.
31. Trimarchi S, Nienaber CA, Rampoldi V, et al. International Registry of Acute Aortic Dissection Investigators: Contemporary results of surgery in acute type A aortic dissection: The International Registry of Acute Aortic Dissection experience. J Thorac Cardiovasc Surg. 2005;129:112-122.
32. Van Karnebeek CD, Naeff MS, Mulder BJ, et al. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child. 2001;84:129-137.
33. Working group “Congenitale cardiologie bij volwassenen” of the Dutch Society of Cardiology. Adult congenital heart disease in the Netherlands: Guidelines 2000. The Hague: The Netherlands Heart Foundation. 2000.